EyePoint (EYPT) Work In Process (2018 - 2026)
EyePoint (EYPT) posted Work In Process of $84000.0 for Q1 2026, down 85.62% sequentially from $584000.0 in Q4 2025, and down 75.22% YoY from $339000.0 in Q1 2025.
Analysis
EyePoint (EYPT) Work In Process (2018 - 2026) Analysis & Trends
EyePoint has reported Work In Process for 9 years, with the latest figure at $84000.0 in Q1 2026.
- Quarterly Work In Process fell 75.22% year-over-year to $84000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84000.0 (down 75.22% YoY) and the FY2025 annual result came in at $584000.0, down 9.88% from the prior year.
- Work In Process declined to $84000.0 in Q1 2026 per EYPT's latest filing, from $584000.0 in the prior quarter.
- Over five years, Work In Process peaked at $1.9 million in Q3 2023 and troughed at $84000.0 in Q1 2026.
- A 5-year average of $869529.4 and a median of $854000.0 in 2022 frame the typical range for Work In Process.
- The sharpest annual moves came in 2022 and 2026: Work In Process soared 288.89% in 2022, then tumbled 75.22% in 2026.
- Over 5 years, Work In Process stood at $1.1 million in 2022, then dropped by 18.18% to $882000.0 in 2023, then retreated by 26.53% to $648000.0 in 2024, then fell by 9.88% to $584000.0 in 2025, then slumped by 85.62% to $84000.0 in 2026.
- According to Business Quant data, Work In Process over the past three periods registered $84000.0, $584000.0, and $498000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 764,000.00 |
| Mar 31, 2026 | 84,000.00 |
| Dec 31, 2025 | 584,000.00 |
| Sep 30, 2025 | 498,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 339,000.00 |
| Dec 31, 2024 | 648,000.00 |
| Sep 30, 2024 | 649,000.00 |
| Jun 30, 2024 | 921,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 882,000.00 |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 854,000.00 |
| Jun 30, 2022 | 595,000.00 |
| Mar 31, 2022 | 671,000.00 |
| Dec 31, 2021 | 405,000.00 |
| Sep 30, 2021 | 571,000.00 |